biological activity | Bitopertin (RG1678, RO-4917838) is a potent inhibitor of GlyT1(glycine transporter 1) with an IC50 of 25 nM in CHO cells. |
target | TargetValue GlyT1 (in cells stable expressing mGlyT1b) 22 nM GlyT1 (in cells stable expressing hGlyT1b) 25nM |
Target | Value |
GlyT1
(in cells stably expressing mGlyT1b)
| 22 nM |
GlyT1
(in cells stably expressing hGlyT1b)
| 25nM |
In vitro study | RG1678 non-competitively inhibits the absorption of [3H] glycine in cells that stably express hGlyT1b and mGlyT1b, and its IC50 is 25±2 nM and 22±5 nM, respectively. RG1678 competitively replaces [3H]ORG24598 and binds human hGlyT1b in CHO cells with a Ki of 8.1 nM. Even if the concentration is mentioned at 30 μM,RG1678 has no effect on the [3H] glycine uptake mediated by hGlyT2. There was no significant difference in the ability of RG1678 to competitively replace [3H]ORG24598 among different species. In hippocampal CA1 pyramidal cells, 30nM, 100nM RG1678 enhanced NMDA-dependent long-term potentiation, while 300 nM RG1678 did not. |
in vivo study | in the microdialysis experiment of cerebrospinal fluid of rats and rats, RG1678 continuously increases the level of extracellular glycine, which is dose-dependent. In mice, RG1678 significantly reduced the rapid movement induced by dextroamphetamine. In rats, RG1678 will prevent the overreaction caused by long-term treatment of phenzyclidine. |